Your browser doesn't support javascript.
loading
Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.
Lilja, Hans; Cronin, Angel M; Dahlin, Anders; Manjer, Jonas; Nilsson, Peter M; Eastham, James A; Bjartell, Anders S; Scardino, Peter T; Ulmert, David; Vickers, Andrew J.
Affiliation
  • Lilja H; Department of Clinical Laboratories, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. liljah@mskcc.org
Cancer ; 117(6): 1210-9, 2011 Mar 15.
Article in En | MEDLINE | ID: mdl-20960520
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Carcinoma / Prostate-Specific Antigen / Early Detection of Cancer Type of study: Diagnostic_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2011 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Carcinoma / Prostate-Specific Antigen / Early Detection of Cancer Type of study: Diagnostic_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2011 Document type: Article Affiliation country: United States Country of publication: United States